1. Home
  2. PCRX vs SMBK Comparison

PCRX vs SMBK Comparison

Compare PCRX & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.81

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo SmartFinancial Inc.

SMBK

SmartFinancial Inc.

HOLD

Current Price

$38.18

Market Cap

706.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
SMBK
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
706.2M
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
PCRX
SMBK
Price
$22.81
$38.18
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$37.20
$38.63
AVG Volume (30 Days)
797.3K
48.3K
Earning Date
05-07-2026
04-20-2026
Dividend Yield
N/A
0.83%
EPS Growth
107.44
39.25
EPS
0.16
2.98
Revenue
$541,533,000.00
N/A
Revenue This Year
$7.10
$17.59
Revenue Next Year
$9.15
$10.30
P/E Ratio
$145.63
$12.95
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$26.31
52 Week High
$27.99
$43.91

Technical Indicators

Market Signals
Indicator
PCRX
SMBK
Relative Strength Index (RSI) 51.03 41.19
Support Level $22.57 $36.45
Resistance Level $23.91 $40.08
Average True Range (ATR) 0.86 1.18
MACD 0.03 0.06
Stochastic Oscillator 54.59 39.84

Price Performance

Historical Comparison
PCRX
SMBK

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

Share on Social Networks: